Canada to invest up to C$214 million for research into domestic-made vaccines: PM Trudeau

By Robin Emmott, Marine Strauss and Kate Abnett Posted on October 23, 2020

Canada’s Prime Minister Justin Trudeau speaks during Question Period in the House of Commons on Parliament Hill in Ottawa

OTTAWA (Reuters) – Canada will invest up to C$214 million ($162.8 million) to help develop a domestically made COVID-19 vaccine, and it has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine, Prime Minister Justin Trudeau said on Friday.

The government will also invest up to C$18.2 million in Vancouver-based biotechnology company Precision NanoSystems Incorporated (PNI) to support a project for pre-clinical and clinical trials for a vaccine.

($1 = 1.3142 Canadian dollars)

(Reporting by Steve Scherer and David Ljunggren; Editing by Chizu Nomiyama)